David A. Culp

3.3k total citations
110 papers, 2.5k citations indexed

About

David A. Culp is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Urology. According to data from OpenAlex, David A. Culp has authored 110 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Surgery, 36 papers in Pulmonary and Respiratory Medicine and 30 papers in Urology. Recurrent topics in David A. Culp's work include Urological Disorders and Treatments (26 papers), Urologic and reproductive health conditions (24 papers) and Pediatric Urology and Nephrology Studies (19 papers). David A. Culp is often cited by papers focused on Urological Disorders and Treatments (26 papers), Urologic and reproductive health conditions (24 papers) and Pediatric Urology and Nephrology Studies (19 papers). David A. Culp collaborates with scholars based in United States, Canada and United Kingdom. David A. Culp's co-authors include R.H. Flocks, Adithya Sathya Narayana, Charles E. Hawtrey, Joseph D. Schmidt, S.A. Loening, Stefan A. Loening, Donald J. Slymen, B Fallon, William W. Bonney and Bernard Fallon and has published in prestigious journals such as JAMA, Nature Communications and Cancer.

In The Last Decade

David A. Culp

104 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David A. Culp United States 28 1.2k 976 643 562 276 110 2.5k
R.H. Flocks United States 25 689 0.6× 1.3k 1.3× 470 0.7× 445 0.8× 309 1.1× 90 2.2k
Benad Goldwasser Israel 27 932 0.8× 521 0.5× 795 1.2× 436 0.8× 246 0.9× 98 2.1k
Timothy D. Moon United States 27 833 0.7× 1.3k 1.3× 694 1.1× 466 0.8× 243 0.9× 61 2.4k
Jack H. Mydlo United States 26 832 0.7× 547 0.6× 714 1.1× 275 0.5× 127 0.5× 83 1.9k
François Desgrandchamps France 27 1.1k 0.9× 983 1.0× 654 1.0× 301 0.5× 213 0.8× 117 2.8k
Amos Shapiro Israel 33 1.5k 1.2× 878 0.9× 647 1.0× 117 0.2× 456 1.7× 106 2.6k
Stephen A. Kramer United States 30 1.2k 1.0× 666 0.7× 1.2k 1.9× 591 1.1× 678 2.5× 103 2.6k
Ilan Leibovitch Israel 29 1.8k 1.5× 913 0.9× 518 0.8× 374 0.7× 109 0.4× 117 3.1k
R. Bruce Bracken United States 28 942 0.8× 715 0.7× 517 0.8× 300 0.5× 91 0.3× 63 1.8k
Christian Schwentner Germany 30 1.6k 1.3× 869 0.9× 1.2k 1.8× 487 0.9× 396 1.4× 208 3.3k

Countries citing papers authored by David A. Culp

Since Specialization
Citations

This map shows the geographic impact of David A. Culp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Culp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Culp more than expected).

Fields of papers citing papers by David A. Culp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Culp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Culp. The network helps show where David A. Culp may publish in the future.

Co-authorship network of co-authors of David A. Culp

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Culp. A scholar is included among the top collaborators of David A. Culp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Culp. David A. Culp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Culp, David A., et al.. (2023). Calreticulin accelerates corneal wound closure and mitigates fibrosis: Potential therapeutic applications. Journal of Cellular and Molecular Medicine. 28(5). e18027–e18027. 3 indexed citations
2.
Tsujinaka, Hiroki, Jie Fu, Jikui Shen, et al.. (2020). Sustained treatment of retinal vascular diseases with self-aggregating sunitinib microparticles. Nature Communications. 11(1). 694–694. 62 indexed citations
3.
Cleland, Jeffrey L., et al.. (2020). Suppression of Murine Choroidal Neovascularization After Systemic Administration of a Targeted Anti-VEGF Therapy. 61(7). 3974–3974. 1 indexed citations
4.
Culp, David A., et al.. (2019). Characterization of the Royal College of Surgeon’s Rat Model Endpoints for Use in Preclinical Ophthalmic Studies. Investigative Ophthalmology & Visual Science. 60(9). 203–203. 1 indexed citations
5.
Yu, Yun, Ward Peterson, Ming Yang, et al.. (2018). Sunitinib-Loaded Injectable Polymer Depot Formulation for Potential Once per Year Treatment of Neovascular Age-related Macular Degeneration (wet AMD). Investigative Ophthalmology & Visual Science. 59(9). 221–221. 1 indexed citations
6.
Yang, Ming, Ward Peterson, Yun Yu, et al.. (2017). Modifications of Sunitinib-Loaded GB-102 Microparticles that Lengthen Drug Release: 9-Months Ocular Tolerability and PK in Rabbit Following IVT Dosing. Investigative Ophthalmology & Visual Science. 58(8). 4115–4115. 2 indexed citations
7.
Culp, David A., Samirkumar R. Patel, & Brian C. Gilger. (2017). Evaluation of Aflibercept in a Laser-Induced Model of Choroidal Neovascularization in Pigs. Investigative Ophthalmology & Visual Science. 58(8). 1990–1990. 1 indexed citations
8.
Gilger, Brian C., David A. Culp, Craig B Struble, et al.. (2017). Nonclinical Development of ENV905 (Difluprednate) Ophthalmic Implant for the Treatment of Inflammation and Pain Associated with Ocular Surgery. Journal of Ocular Pharmacology and Therapeutics. 34(1-2). 161–169. 8 indexed citations
9.
Yang, Ming, Ward Peterson, Yun Yu, et al.. (2016). GB-102 for Wet AMD: A Novel Injectable Formulation that Safely Delivers Active Levels of Sunitinib to the Retina and RPE/Choroid for Over Four Months. Investigative Ophthalmology & Visual Science. 57(12). 5037–5037. 8 indexed citations
10.
Mobley, William C., Stefan A. Loening, Adithya Sathya Narayana, & David A. Culp. (1986). Use of intravesical cisplatin and mitomycin-C for recurrent transitional cell carcinoma of bladder refractory to thiotepa. Urology. 27(4). 335–339. 1 indexed citations
11.
Hawtrey, Charles E., et al.. (1983). Ureterovesical Reflux in an Adolescent and Adult Population. The Journal of Urology. 130(6). 1067–1069. 3 indexed citations
12.
Narayana, Adithya Sathya, S.A. Loening, & David A. Culp. (1981). Flutamide in the Treatment of Metastatic Carcinoma of the Prostate. British Journal of Urology. 53(2). 152–153. 33 indexed citations
13.
Narayana, Adithya Sathya, S.A. Loening, Charles E. Hawtrey, et al.. (1980). Penile Prostheses for the Treatment of Impotence. British Journal of Urology. 52(6). 575–578. 5 indexed citations
14.
Stamler, Frederic W., et al.. (1974). Interstitial cystitis followed by total cystectomy. Urology. 3(4). 481–485. 11 indexed citations
15.
Thornbury, John R. & David A. Culp. (1967). The urinary tract : roentgen diagnosis. 2 indexed citations
16.
Flocks, R.H. & David A. Culp. (1959). The Perineum in Epispadias. The Journal of Urology. 81(3). 443–447.
17.
Flocks, R.H., et al.. (1959). Lymphatic Spread from Prostatic Cancer. The Journal of Urology. 81(1). 194–196. 153 indexed citations
18.
Culp, David A., et al.. (1957). Comparative Studies of Urographic Media. The Journal of Urology. 78(4). 493–495. 7 indexed citations
19.
Flocks, R.H., et al.. (1954). The Treatment of Carcinoma of the Prostate by Interstitial Radiation with Radioactive Gold (Au 198 ): A Follow-Up Report. The Journal of Urology. 71(5). 628–633. 31 indexed citations
20.
Culp, David A.. (1953). Testicular Neoplasms: An Analysis of 113 Cases. The Journal of Urology. 70(2). 282–295. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R.H. Flocks Breakdown of academic impact, for papers by Benad Goldwasser Breakdown of academic impact, for papers by Timothy D. Moon Breakdown of academic impact, for papers by Jack H. Mydlo Breakdown of academic impact, for papers by François Desgrandchamps Breakdown of academic impact, for papers by Amos Shapiro Breakdown of academic impact, for papers by Stephen A. Kramer Breakdown of academic impact, for papers by Ilan Leibovitch Breakdown of academic impact, for papers by R. Bruce Bracken Breakdown of academic impact, for papers by Christian Schwentner
Rankless by CCL
2026